Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

During the Trading Day
83.56 +0.15 / +0.18%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
83.98 +0.42 / +0.50%
 
Volume: 28.8K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$6.6B

Company Description

DexCom, Inc. is a medical device manufacturing company. The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F. Burd in May 1999 and is headquartered in San Diego, CA.

Contact Information

DexCom, Inc.
6340 Sequence Drive
San Diego California 92121
P:(858) 200-0200
Investor Relations:

Employees

Shareholders

Mutual fund holders58.73%
Other institutional36.35%
Individual stakeholders13.54%

Top Executives

Kevin Ronald SayerPresident, CEO, Chief Operating Officer & Director
Jess RoperChief Financial Officer & Senior Vice President
Jacob LeachVice President-Research & Development
Jorge A. ValdesChief Technology Officer
John D. ListerSenior Vice President & General Counsel